These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6718599)

  • 1. [Report of experiences with high dosage Hydiphen infusion treatment of depressive syndromes].
    Dreves B; Manthey I; Schmieter K; Haiduk A
    Psychiatr Neurol Med Psychol (Leipz); 1984 Feb; 36(2):95-100. PubMed ID: 6718599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Combined chlorimipramine and maprotiline therapy in therapy-resistant depressions].
    Soucek K
    Act Nerv Super (Praha); 1982 May; 24(2):88-9. PubMed ID: 7102229
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical evaluation of Hydiphen in the treatment of endogenous depression].
    Nowakowska C; Chłopocka-Woźniak M; Strzyzewski W
    Psychiatr Pol; 1989; 23(1):10-7. PubMed ID: 2682710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical experience with maprotilin and maprotilin/clomipramine infusions in resistant depression.
    Zapletálek M; Zbytovský J; Kudrnová K
    Act Nerv Super (Praha); 1982 May; 24(2):73-6. PubMed ID: 7102227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clomipramine in the treatment of depressive syndrome: the results from the open study of Hydiphen].
    Myszka DM
    Psychiatr Pol; 1996; 30(6):1003-8. PubMed ID: 9132762
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical experience with clomipramine (Hydiphen) and desipramine (Petytyl) by parenteral administration in the treatment of endogenous depression with signs of pharmacoresistance].
    Cesková E; Náhunek K; Rysánek R; Svestka J
    Cesk Psychiatr; 1983 Apr; 79(2):94-101. PubMed ID: 6345009
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical characteristics and typological classification of endogenous depression resistant to treatment].
    Bondar' VV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1992; 92(1):84-8. PubMed ID: 1319660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Our first experience with the antidepressive Hydiphen (clomipramine)].
    Kolomazník M; Hronek J; Petránová T; Jankových V; Karásková M; Kryl L
    Cesk Psychiatr; 1983 Feb; 79(1):23-8. PubMed ID: 6839388
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of therapy resistant depressions with high dose clomipramine].
    Laux G; Reimer F
    Int Pharmacopsychiatry; 1979; 14(5):294-9. PubMed ID: 536186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of short-term venlafaxine versus lithium monotherapy for bipolar II major depressive episode: a randomized open-label study.
    Amsterdam JD; Shults J
    J Clin Psychopharmacol; 2008 Apr; 28(2):171-81. PubMed ID: 18344727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Subsequent manic onset caused by association of vigabatrin-clomipramine].
    Sastre-Garau P; Thomas P; Beaussart M; Goudemand M
    Encephale; 1993; 19(4):351-2. PubMed ID: 8275923
    [No Abstract]   [Full Text] [Related]  

  • 12. [Imipramine and neuro-psychiatry. Retrospective study of 557 out-patients treated in a neuro-psychiatric unit (author's transl)].
    Brion S; Boulenger JP
    Encephale; 1982; 8(1):49-63. PubMed ID: 7094871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Noveril treatment of patients with treatment-resistant depressions (comparative evaluation of technics of intravenous drip administration)].
    Panteleeva GP; Borisova KE; Mikhaĭlova NM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(8):1221-6. PubMed ID: 6149662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-receptor stimulation in the treatment of depression.
    Simon P; Lecrubier Y; Jouvent R; Puech A; Widlocher D
    Adv Biochem Psychopharmacol; 1984; 39():293-9. PubMed ID: 6380225
    [No Abstract]   [Full Text] [Related]  

  • 15. [Management of treatment-resistant depression without ECT (author's transl)].
    Kielholz P; Terzani S; Gastpar M; Adams C
    Dtsch Med Wochenschr; 1981 May; 106(21):671-3. PubMed ID: 6113126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mood stabilizer augmentation in apparently "unipolar" MDD: predictors of response in the naturalistic French national EPIDEP study.
    Hantouche EG; Akiskal HS; Lancrenon S; Chatenêt-Duchêne L
    J Affect Disord; 2005 Feb; 84(2-3):243-9. PubMed ID: 15708422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous chlorimipramine and depressive subtypes.
    Escobar JI; Teeter RR; Tuason VB; Schiele BC
    Dis Nerv Syst; 1976 Jun; 37(6):325-8. PubMed ID: 1277983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of therapy-refractory depressions].
    Pöldinger W; Alac S; Krebs-Roubicek E
    Act Nerv Super (Praha); 1982 May; 24(2):55-62. PubMed ID: 6125075
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of therapy-resistant depressions. Results of combined infusion treatment].
    Kielholz P; Terzani S; Gastpar M; Adams C
    Schweiz Med Wochenschr; 1982 Aug; 112(31-32):1090-5. PubMed ID: 7134934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obsessive-compulsive-bipolar comorbidity: a systematic exploration of clinical features and treatment outcome.
    Perugi G; Toni C; Frare F; Travierso MC; Hantouche E; Akiskal HS
    J Clin Psychiatry; 2002 Dec; 63(12):1129-34. PubMed ID: 12523872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.